![Cytopoint - ein neues Medikament zur Juckreizlinderung beim Hund - Tierarztpraxis IdsteinTierarztpraxis Idstein Cytopoint - ein neues Medikament zur Juckreizlinderung beim Hund - Tierarztpraxis IdsteinTierarztpraxis Idstein](http://tierarztpraxis-idstein.de/wp-content/uploads/2018/02/IMG_3523-300x225.jpg)
Cytopoint - ein neues Medikament zur Juckreizlinderung beim Hund - Tierarztpraxis IdsteinTierarztpraxis Idstein
![A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA - Souza - 2018 - Veterinary Dermatology - Wiley Online Library A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA - Souza - 2018 - Veterinary Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/cd5d4457-dca7-4aba-a72d-4c352ff9b499/vde.2018.29.issue-6.cover.jpg)
A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA - Souza - 2018 - Veterinary Dermatology - Wiley Online Library
![Zoetis erhält Vermarktungszulassung der Europäischen Kommission für Cytopoint® (Lokivetmab) | Business Wire Zoetis erhält Vermarktungszulassung der Europäischen Kommission für Cytopoint® (Lokivetmab) | Business Wire](https://mms.businesswire.com/media/20170426006935/de/583143/5/Image.jpg)
Zoetis erhält Vermarktungszulassung der Europäischen Kommission für Cytopoint® (Lokivetmab) | Business Wire
Tierklinik Bielefeld - Ganz neue Therapie für Hunde mit Allergien! Massive Linderung des Juckreizes. Weniger Entzündungen. Verbesserte Gesundheit. Mehr Lebensqualität. Das belegen Studien. Erst im September kommt das Präparat „Cytopoint“ in Deutschland
![Onset and duration of action of lokivetmab in a canine model of IL‐31 induced pruritus - Fleck - 2021 - Veterinary Dermatology - Wiley Online Library Onset and duration of action of lokivetmab in a canine model of IL‐31 induced pruritus - Fleck - 2021 - Veterinary Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2b16a864-9caa-409a-b5b0-b7114346c24f/vde12943-fig-0001-m.jpg)
Onset and duration of action of lokivetmab in a canine model of IL‐31 induced pruritus - Fleck - 2021 - Veterinary Dermatology - Wiley Online Library
![Lokivetmab therapy for pruritus in a dog with cutaneous mastocytosis - Meichner - 2019 - Veterinary Dermatology - Wiley Online Library Lokivetmab therapy for pruritus in a dog with cutaneous mastocytosis - Meichner - 2019 - Veterinary Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c8b4a062-f971-47cb-8715-0218e6eca189/vde.2019.30.issue-1.cover.jpg)
Lokivetmab therapy for pruritus in a dog with cutaneous mastocytosis - Meichner - 2019 - Veterinary Dermatology - Wiley Online Library
![Zoetis erhält Vermarktungszulassung der Europäischen Kommission für Cytopoint® (Lokivetmab) | Business Wire Zoetis erhält Vermarktungszulassung der Europäischen Kommission für Cytopoint® (Lokivetmab) | Business Wire](https://mms.businesswire.com/media/20170426006935/de/402649/5/Zoetis_c.jpg)
Zoetis erhält Vermarktungszulassung der Europäischen Kommission für Cytopoint® (Lokivetmab) | Business Wire
![A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis – topic of research paper in Veterinary science. Download A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis – topic of research paper in Veterinary science. Download](https://cyberleninka.org/viewer_images/667175/f/1.png)